These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 29603900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, Kenyon C, Wouters K, Laga M.
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [Abstract] [Full Text] [Related]

  • 7. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP.
    Jongen VW, Hoornenborg E, van den Elshout MA, Boyd A, Zimmermann HM, Coyer L, Davidovich U, Anderson PL, de Vries HJ, Prins M, Schim van der Loeff MF, Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative.
    J Int AIDS Soc; 2021 May; 24(5):e25708. PubMed ID: 33973373
    [Abstract] [Full Text] [Related]

  • 8. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Liegler T, Rawlings MK, Trainor N, Blue RW, Estrada Y, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA.
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [Abstract] [Full Text] [Related]

  • 9. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study.
    Laurent C, Dembélé Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traoré I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Fayé-Ketté H, Koné A, Diandé S, Dagnra CA, Serrano L, Diallo F, Mensah E, Dah TTE, Anoma C, Vuylsteke B, Spire B, CohMSM-PrEP Study Group.
    Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794
    [Abstract] [Full Text] [Related]

  • 10. Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.
    Reyniers T, Nöstlinger C, Laga M, De Baetselier I, Crucitti T, Wouters K, Smekens B, Buyze J, Vuylsteke B.
    J Acquir Immune Defic Syndr; 2018 Oct 01; 79(2):186-194. PubMed ID: 29975211
    [Abstract] [Full Text] [Related]

  • 11. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study.
    Torres Silva MS, Torres TS, Coutinho C, Ismério Moreira R, da Costa Leite I, Cunha M, da Costa Leite PHA, Cáceres CF, Vega-Ramírez H, Konda KA, Guanira J, Valdez Madruga J, Wagner Cardoso S, Benedetti M, Pimenta MC, Hoagland B, Grinsztejn B, Gonçalves Veloso V, ImPrEP Study Group.
    Lancet HIV; 2024 Oct 01; 11(10):e670-e679. PubMed ID: 39243787
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group.
    Lancet HIV; 2017 Sep 01; 4(9):e402-e410. PubMed ID: 28747274
    [Abstract] [Full Text] [Related]

  • 13. Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis.
    Zimmermann HM, Eekman SW, Achterbergh RC, Schim van der Loeff MF, Prins M, de Vries HJ, Hoornenborg E, Davidovich U, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM).
    J Int AIDS Soc; 2019 Oct 01; 22(10):e25389. PubMed ID: 31612621
    [Abstract] [Full Text] [Related]

  • 14. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM, Stall RD, Rebe K, Egan JE, De Swardt G, Struthers H, McIntyre JA.
    AIDS Behav; 2016 Dec 01; 20(Suppl 3):357-364. PubMed ID: 27631366
    [Abstract] [Full Text] [Related]

  • 15. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ, PrEPX Study Team.
    JAMA; 2019 Apr 09; 321(14):1380-1390. PubMed ID: 30964528
    [Abstract] [Full Text] [Related]

  • 16. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, Chinbunchorn T, Janyam S, Linjongrat D, Puthanakit T, CE-PID - TRC Adolescent Study Team.
    J Int AIDS Soc; 2020 Sep 09; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [Abstract] [Full Text] [Related]

  • 17. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA, Torres TS, Mariño G, Ramos A, Moreira RI, Leite IC, Cunha M, Jalil EM, Hoagland B, Guanira JV, Benedetti M, Pimenta C, Vermandere H, Bautista-Arredondo S, Vega-Ramirez H, Veloso VG, Caceres CF, Grinsztejn B, ImPrEP Study Group.
    J Int AIDS Soc; 2022 Oct 09; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [Abstract] [Full Text] [Related]

  • 18. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.
    Jongen VW, Reyniers T, Ypma ZM, Schim van der Loeff MF, Davidovich U, Zimmermann HM, Coyer L, van den Elshout MA, de Vries HJ, Wouters K, Smekens T, Vuylsteke B, Prins M, Laga M, Hoornenborg E.
    J Int AIDS Soc; 2021 Aug 09; 24(8):e25768. PubMed ID: 34382345
    [Abstract] [Full Text] [Related]

  • 19. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
    Wu D, Tao H, Dai J, Liang H, Huang A, Zhong X.
    Int J Environ Res Public Health; 2019 Dec 09; 16(24):. PubMed ID: 31818006
    [Abstract] [Full Text] [Related]

  • 20. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D, ANRS PREVENIR Study Group.
    Lancet HIV; 2022 Aug 09; 9(8):e554-e562. PubMed ID: 35772417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.